Through a national collaboration, large Danish biobanks, at hospitals, universities and other research institutions, regularly submit information about their biological samples to the Danish Biobank Register. Data from the biobanks are linked to register information, so biological samples can be cross-referenced to diseases, operations, demographic information and much more. Samples can be taken at time of diagnosis, but also years before, enabling early biomarkers to be identified. Aggregated results about the available biological material is displayed to researchers around the world through a web-based search system, that so far contains information about 22 million biological samples from 5.4 million Danes. Learn more ›
By using the Danish Biobank Register, Bjarke Feenstra and collaborators were able to identify 2000 blood samples in the Danish National Biobank from children experiencing Febrile Seizures (FS). In rare situations, FS occur as an adverse event following MMR vaccination. Through genome-wide association analyses, the researchers identified two genetic variants that specifically predispose to FS after MMR vaccination. The study also identified four variants for FS in general. The large sample size available through the Danish National Biobank, made it possible to delineate the genetic contribution to FS in children, thereby opening a completely new chapter in seizure genetics. Learn more ›
Ministerial delegation visit from Croatia
"I am pleased with everything I have seen and with the hospitality extended to me and my colleagues during our stay in Denmark. We are grateful to the Healthcare DENMARK team for being wonderful hosts to us and for the excellent organization of our visit."
- Dario Nakić, Croatian Minister of Health